SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5tpc'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I1E_A_DM2A3001_1
(BOTULINUM NEUROTOXIN
TYPE B)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
5 / 9 GLU A1203
GLY A1251
HIS A1253
SER A1264
TYR A1267
NGA  A1303 (-3.1A)
None
GAL  A1304 (-3.7A)
GAL  A1304 (-2.7A)
GAL  A1304 ( 4.2A)
0.59A 1i1eA-5tpcA:
29.7
1i1eA-5tpcA:
18.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I1E_A_DM2A3001_1
(BOTULINUM NEUROTOXIN
TYPE B)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
5 / 9 GLU A1203
GLY A1251
SER A1264
TRP A1266
TYR A1267
NGA  A1303 (-3.1A)
None
GAL  A1304 (-2.7A)
GAL  A1304 ( 4.1A)
GAL  A1304 ( 4.2A)
0.66A 1i1eA-5tpcA:
29.7
1i1eA-5tpcA:
18.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LHV_A_NOGA301_1
(SEX HORMONE-BINDING
GLOBULIN)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
4 / 8 SER A 922
ASP A 910
PHE A 906
ASN A 912
None
1.07A 1lhvA-5tpcA:
8.9
1lhvA-5tpcA:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SBR_B_VIBB503_1
(YKOF)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
4 / 7 SER A1027
ILE A 983
ILE A1029
THR A1020
None
0.81A 1sbrB-5tpcA:
undetectable
1sbrB-5tpcA:
15.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2D0K_A_FOLA1161_0
(DIHYDROFOLATE
REDUCTASE)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
6 / 12 ILE A 965
LEU A 916
PHE A1055
ILE A 898
LEU A 881
ILE A1053
None
1.36A 2d0kA-5tpcA:
undetectable
2d0kA-5tpcA:
16.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y69_P_CHDP1265_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 3)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
4 / 5 PHE A 945
PHE A1072
LEU A1074
PHE A 941
None
1.36A 2y69P-5tpcA:
undetectable
2y69W-5tpcA:
undetectable
2y69P-5tpcA:
18.91
2y69W-5tpcA:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YFB_A_ACTA501_0
(METHYL-ACCEPTING
CHEMOTAXIS
TRANSDUCER)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
4 / 7 ASP A1171
ARG A1175
ILE A1096
TYR A1107
None
1.04A 2yfbA-5tpcA:
undetectable
2yfbA-5tpcA:
17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YGQ_A_PCFA1275_0
(WNT INHIBITORY
FACTOR 1)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
6 / 12 ILE A1053
LEU A 928
ILE A 965
ILE A 878
PHE A1072
VAL A1017
None
1.42A 2ygqA-5tpcA:
undetectable
2ygqA-5tpcA:
18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZW9_B_SAMB801_1
(LEUCINE CARBOXYL
METHYLTRANSFERASE 2)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
4 / 8 ILE A 878
ASN A1073
SER A 944
ASP A 875
None
1.12A 2zw9B-5tpcA:
undetectable
2zw9B-5tpcA:
20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPD_B_SAMB1000_1
(UNCHARACTERIZED
PROTEIN MJ0100)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
3 / 3 ASN A 935
ASN A1051
GLU A 969
None
0.75A 3kpdC-5tpcA:
undetectable
3kpdC-5tpcA:
14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPD_C_SAMC1000_0
(UNCHARACTERIZED
PROTEIN MJ0100)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
3 / 3 ASN A 935
ASN A1051
GLU A 969
None
0.87A 3kpdB-5tpcA:
undetectable
3kpdB-5tpcA:
14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3O94_B_NCAB192_0
(NICOTINAMIDASE)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
5 / 11 LEU A 928
ASP A 890
LEU A1074
ILE A 878
SER A 877
None
1.44A 3o94B-5tpcA:
undetectable
3o94B-5tpcA:
19.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3O94_C_NCAC192_0
(NICOTINAMIDASE)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
5 / 11 LEU A 928
ASP A 890
LEU A1074
ILE A 878
SER A 877
None
1.42A 3o94C-5tpcA:
undetectable
3o94C-5tpcA:
19.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3O94_D_NCAD192_0
(NICOTINAMIDASE)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
5 / 11 LEU A 928
ASP A 890
LEU A1074
ILE A 878
SER A 877
None
1.41A 3o94D-5tpcA:
undetectable
3o94D-5tpcA:
19.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P50_E_PFLE319_1
(GLR4197 PROTEIN)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
4 / 7 ILE A 984
TYR A 962
THR A 963
ILE A 964
None
0.98A 3p50E-5tpcA:
undetectable
3p50E-5tpcA:
20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_B_9PLB501_1
(CYTOCHROME P450 2A6)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
5 / 9 PHE A1055
PHE A1072
ASN A 966
ILE A1053
THR A 943
None
1.33A 3t3rB-5tpcA:
undetectable
3t3rB-5tpcA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_C_9PLC501_1
(CYTOCHROME P450 2A6)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
5 / 9 PHE A1055
PHE A1072
ASN A 966
ILE A1053
THR A 943
None
1.33A 3t3rC-5tpcA:
undetectable
3t3rC-5tpcA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W67_C_VIVC301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
5 / 12 TYR A1001
ILE A1015
SER A 957
ILE A 964
LEU A1057
None
1.10A 3w67C-5tpcA:
undetectable
3w67C-5tpcA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AGA_A_ACTA1131_0
(LYSOZYME C)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
3 / 3 ASN A1238
ASP A1246
ASN A1268
None
0.75A 4agaA-5tpcA:
undetectable
4agaA-5tpcA:
15.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OLM_A_198A1001_2
(ANDROGEN RECEPTOR)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
4 / 6 MET A1004
ILE A 983
ILE A 984
VAL A 998
None
1.02A 4olmA-5tpcA:
undetectable
4olmA-5tpcA:
18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UC1_A_486A801_2
(GLUCOCORTICOID
RECEPTOR)
5tpc BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum)
3 / 3 TRP A 974
MET A 968
ASN A 966
None
1.32A 5uc1B-5tpcA:
undetectable
5uc1B-5tpcA:
11.22